Close Menu

NEW YORK — Curi Bio said on Thursday that it has acquired Dana Solutions, a Palo Alto, California-based developer of artificial intelligence (AI) technologies for in vitro cell-based assays.

Curi offers a range of induced pluripotent stem cell (iPSC)-based products for drug discovery including its Car(ina) cardiac microtissue model, as well as its NanoSurface Plate line of microplates.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Apr
28
Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development. 

May
04
Sponsored by
Akoya Biosciences

Recently developed technologies for digital imaging and highly multiplexed immunohistochemistry (mIHC) advancing the field of histology into a quantitative era, allowing for more complex descriptions of tissue architecture.

May
06
Sponsored by
Akoya Biosciences

Integrating complementary data sets provides a powerful tool to study complex biological processes.

May
11
Sponsored by
Akoya Biosciences

Our expert panelists will review their own strategies for addressing the challenges of integrative multiomic analysis and will share best practices for this rapidly evolving field.